• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Phenotypic instability of Saos-2 cells in long-term culture.

作者信息

Hausser Heinz-Juergen, Brenner Rolf E

机构信息

Division for Biochemistry of Joint and Connective Tissue Diseases, University of Ulm, Germany.

出版信息

Biochem Biophys Res Commun. 2005 Jul 22;333(1):216-22. doi: 10.1016/j.bbrc.2005.05.097.

DOI:10.1016/j.bbrc.2005.05.097
PMID:15939397
Abstract

The human osteosarcoma cell line Saos-2 is widely used as a model system for human osteoblastic cells, though its phenotypic stability has not been ascertained. We therefore propagated these cells over 100 passages and compared relevant phenotypic properties. In general, higher passage cells exhibited higher proliferation rates and lower specific alkaline phosphatase activities, though mineralization was significantly more pronounced in cultures of late passage cells. Whereas expression of most genes investigated did not vary profoundly, some genes exhibited remarkable differences. Decorin, for instance, that has been discussed as a regulator of proliferation and mineralization, is strongly expressed only in early passage cells, and two receptors for pleiotrophin and midkine exhibited an almost mutually exclusive expression pattern in early and late passage cells, respectively. Our observations indicate that special care is required when results obtained with Saos-2 cells with different culture history are to be compared.

摘要

相似文献

1
Phenotypic instability of Saos-2 cells in long-term culture.
Biochem Biophys Res Commun. 2005 Jul 22;333(1):216-22. doi: 10.1016/j.bbrc.2005.05.097.
2
A proteomic study on human osteoblastic cells proliferation and differentiation.一项关于人成骨细胞增殖与分化的蛋白质组学研究。
Proteomics. 2006 Jun;6(12):3520-32. doi: 10.1002/pmic.200500858.
3
P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2.抑癌基因P53影响人骨肉瘤细胞系SAOS-2对电离辐射的基因组失衡选择。
Int J Radiat Biol. 2008 Jul;84(7):591-601. doi: 10.1080/09553000802195349.
4
Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.前列腺特异性抗原调节参与骨重塑的基因,并诱导人骨肉瘤细胞系SaOS-2的成骨细胞分化。
Clin Cancer Res. 2006 Mar 1;12(5):1420-30. doi: 10.1158/1078-0432.CCR-05-1849.
5
Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts.与人类成骨细胞相比,骨肉瘤细胞系MG-63、Saos-2和U-2 OS的特性分析。
Anticancer Res. 2004 Nov-Dec;24(6):3743-8.
6
In vitro proliferation and osteoblastic phenotype expression of cells derived from human vertebral lamina and iliac crest.人椎板和髂嵴来源细胞的体外增殖及成骨细胞表型表达
Spine (Phila Pa 1976). 2009 Jul 1;34(15):1549-53. doi: 10.1097/BRS.0b013e3181a9c087.
7
Subculture affects the phenotypic expression of human periodontal ligament cells and their response to fibroblast growth factor-2 and bone morphogenetic protein-7 in vitro.传代培养影响人牙周膜细胞的表型表达及其在体外对成纤维细胞生长因子-2和骨形态发生蛋白-7的反应。
J Periodontal Res. 2008 Oct;43(5):563-9. doi: 10.1111/j.1600-0765.2008.01087.x. Epub 2008 Jul 4.
8
Nuclear matrix proteins distinguish normal diploid osteoblasts from osteosarcoma cells.核基质蛋白可区分正常二倍体成骨细胞与骨肉瘤细胞。
Cancer Res. 1994 Jan 1;54(1):28-32.
9
Behavior of two osteoblast-like cell lines cultured on machined or rough titanium surfaces.在经过机械加工的或粗糙的钛表面培养的两种成骨细胞样细胞系的行为。
Clin Oral Implants Res. 2009 Jan;20(1):50-5. doi: 10.1111/j.1600-0501.2008.01594.x.
10
Altered morphology, nuclear stability and adhesion of highly metastatic derivatives of osteoblast-like SAOS-2 osteosarcoma cells.成骨样SAOS-2骨肉瘤细胞高转移衍生物的形态改变、核稳定性及黏附性
Anticancer Res. 2007 Nov-Dec;27(6B):3973-9.

引用本文的文献

1
Establishment of patient-derived 3D in vitro models of sarcomas: literature review and guidelines on behalf of the FORTRESS working group.肉瘤患者来源的3D体外模型的建立:代表FORTRESS工作组的文献综述与指南
Neoplasia. 2025 Jul;65:101171. doi: 10.1016/j.neo.2025.101171. Epub 2025 May 3.
2
Tumor Growth, Proliferation and Diffusion in Osteosarcoma.骨肉瘤中的肿瘤生长、增殖与扩散
Acta Biotheor. 2025 Mar 18;73(1):4. doi: 10.1007/s10441-025-09494-4.
3
Tissue-engineered patient-derived osteosarcoma models dissecting tumour-bone interactions.
组织工程化患者来源骨肉瘤模型解析肿瘤-骨相互作用。
Cancer Metastasis Rev. 2024 Nov 27;44(1):8. doi: 10.1007/s10555-024-10218-2.
4
Energy level as a theranostic factor for successful therapy of tissue injuries with polyphosphate: the triad metabolic energy - mechanical energy - heat.能量水平作为多聚磷酸盐治疗组织损伤成功的治疗因子:代谢能量-机械能-热能三联体。
Theranostics. 2024 Aug 19;14(13):5262-5280. doi: 10.7150/thno.100622. eCollection 2024.
5
Patient-Derived Xenografts: Historical Evolution, Immunocompromised Host Models, and Translational Significance.患者来源异种移植物:历史演变、免疫缺陷宿主模型和转化意义。
Methods Mol Biol. 2024;2806:1-8. doi: 10.1007/978-1-0716-3858-3_1.
6
Orthotopic and metastatic tumour models in preclinical cancer research.临床前癌症研究中的原位和转移瘤模型。
Pharmacol Ther. 2024 May;257:108631. doi: 10.1016/j.pharmthera.2024.108631. Epub 2024 Mar 11.
7
Regulation of the P53 tumor suppressor gene and the Mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment.通过智能温敏型 PLGA 载体传递活性草药成分调节 P53 肿瘤抑制基因和 Mcl-2 癌基因表达,以改善骨肉瘤治疗。
Med Oncol. 2024 Jan 30;41(3):68. doi: 10.1007/s12032-023-02291-4.
8
Breast cancer brain metastasis: from etiology to state-of-the-art modeling.乳腺癌脑转移:从病因到前沿建模
J Biol Eng. 2023 Jun 29;17(1):41. doi: 10.1186/s13036-023-00352-w.
9
Chromosomal instability and its effect on cell lines.染色体不稳定性及其对细胞系的影响。
Cancer Rep (Hoboken). 2023 Jun;6(6):e1822. doi: 10.1002/cnr2.1822. Epub 2023 Apr 24.
10
Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy.患者来源的异种移植瘤或类器官在传统和自组装肿瘤免疫治疗药物发现中的应用
Front Oncol. 2023 Apr 4;13:1122322. doi: 10.3389/fonc.2023.1122322. eCollection 2023.